Dubourg J, Fouqueray P, Thang C, Grouin JM, et al. Efficacy and Safety of Imeglimin Monotherapy Versus Placebo in Japanese Patients With Type 2 Diabetes (TIMES 1): A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Phase 3 Trial. Diabetes Care 2021 Feb 11. pii: dc20-0763. doi: 10.2337/dc20-0763.
PMID: 33574125